TrialActa oncologica (Stockholm, Sweden)2024

Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit.

Terese Engström et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.